SF4498 (Legislative Session 94 (2025-2026))
Strategies in the comprehensive drug overdose and morbidity program administered by the commissioner of health modification
Related bill: HF4415
AI Generated Summary
Purpose
This bill amends the state’s health laws to strengthen and expand the comprehensive drug overdose and morbidity program run by the commissioner of health. The goal is to prevent overdoses, better track and understand drug-related health issues, and address associated harms across Minnesota through integrated, targeted strategies.
Main Provisions and What the Bill Seeks to Accomplish
1) Access to nonnarcotic pain management - Advance access to evidence-based nonnarcotic pain management services.
2) Culturally specific interventions - Implement culturally specific prevention programs and interventions with populations and community groups in greatest need, including pregnant individuals and their infants.
3) Homelessness and overdose prevention - Enhance overdose prevention and supportive services for people experiencing homelessness. - This includes funding for emergency and short-term housing subsidies through a homeless overdose prevention hub and expanding support for syringe services programs statewide.
4) Recovery-friendly workplaces - Equip employers to promote employee health and wellbeing by addressing substance misuse and overdose. - Develop and implement a Recovery Friendly Workplace Initiative in collaboration with relevant state agencies. - Conduct outreach to the business community to form public-private partnerships and encourage adoption of recovery-friendly workplace policies and practices.
5) Outbreak detection and substance identification - Improve detection of overdoses and identify substances involved by expanding the Minnesota Drug Overdose and Substance Use Surveillance Activity (MNDOSA).
6) Community prevention programs - Implement Tackling Overdose With Networks (TOWN) community prevention programs.
7) Focus on pregnancy-related overdose and morbidity - Identify, address, and respond to drug overdose and morbidity in those who are pregnant or have just given birth using multitiered approaches, including: - Promoting medication-assisted treatment (MAT) options. - Supporting programs that use evidence-based care models for mental health and substance use disorders. - Collaborating with interdisciplinary and professional organizations to focus on quality improvement related to substance use disorder. - Implementing recommendations from the maternal mortality review committee related to substance use disorder as appropriate. - Design and operate a system to assess, address, and prevent the impacts of drug overdoses and morbidity on pregnant individuals, their infants, and children. The commissioner may: - Inform health care providers and the public about the prevalence, risks, conditions, and treatments related to substance use disorders involving pregnancies, infants, and children. - Identify communities, families, infants, and children affected by substance use disorders to guide focused interventions, prevention, and services.
Significant Changes to Existing Law
- The bill amends Minnesota Statutes 2024, section 144.0528, subdivision 2, to establish and expand the comprehensive drug overdose and morbidity program with the above strategies.
- Adds new initiatives and program components (e.g., Recovery Friendly Workplace, expanded homelessness supports, expanded syringe services, enhanced surveillance (MNDOSA), and pregnancy-focused interventions) to the program administered by the commissioner of health.
- Establishes a framework for ongoing outreach, collaboration, and information sharing to inform providers and the public, as well as targeted interventions for pregnant people, infants, and children.
Terminology and Concepts to Note
- Comprehensive drug overdose and morbidity program
- Epidemiologic investigations, surveillance, and evaluation
- Evidence-based nonnarcotic pain management
- Culturally specific interventions
- Homelessness and homelessness services
- Homeless overdose prevention hub
- Syringe services programs
- Recovery Friendly Workplace Initiative
- Public-private partnerships
- Minnesota Drug Overdose and Substance Use Surveillance Activity (MNDOSA)
- Tackling Overdose With Networks (TOWN)
- Medication-assisted treatment (MAT)
- Substance use disorder (SUD)
- Pregnant individuals, pregnancy, infants, and children
- Maternal mortality review committee
- Multitiered approaches to prevention and services
Relevant Terms comprehensive drug overdose and morbidity program epidemiologic investigations surveillance evidence-based nonnarcotic pain management culturally specific interventions homelessness homeless overdose prevention hub syringe services programs Recovery Friendly Workplace Initiative Minnesota Drug Overdose and Substance Use Surveillance Activity (MNDOSA) Tackling Overdose With Networks (TOWN) medication-assisted treatment (MAT) substance use disorder (SUD) pregnant individuals / pregnancy / infants / children maternal mortality review committee public-private partnerships recovery-friendly workplace policies
Bill text versions
- Introduction PDF PDF file
Actions
| Date | Chamber | Where | Type | Name | Committee Name |
|---|---|---|---|---|---|
| March 17, 2026 | Senate | Action | Introduction and first reading | ||
| March 17, 2026 | Senate | Action | Referred to | Health and Human Services |
Citations
[
{
"analysis": {
"added": [
"Advance access to evidence-based nonnarcotic pain management services.",
"Implement culturally specific interventions and prevention programs with populations in greatest need.",
"Enhance overdose prevention and supportive services for people experiencing homelessness, including funding for emergency and short-term housing subsidies through the homeless overdose prevention hub and expanding syringe services.",
"Equip employers to promote employee health and well-being by addressing substance misuse and drug overdose, including development of a Recovery Friendly Workplace Initiative and related outreach.",
"Improve outbreak detection and identification of substances involved in overdoses through expansion of the Minnesota Drug Overdose and Substance Use Surveillance (MNDOSA).",
"Identify, address, and respond to drug overdose and morbidity in pregnant individuals or those recently post-partum through multitiered approaches (including promotion of MAT, support for evidence-based care models, collaboration with professional organizations on quality improvement, and incorporating maternal mortality review recommendations).",
"Design a system to assess and prevent the impacts of drug overdose and morbidity on pregnant individuals, their infants, and children."
],
"removed": [],
"summary": "This bill amends Minnesota Statutes 2024 section 144.0528, subdivision 2, to establish and expand the comprehensive drug overdose and morbidity program administered by the commissioner of health. The plan outlines integrated strategies including pain management, culturally specific interventions, homelessness-related prevention and housing subsidies, workforce recovery initiatives, enhanced outbreak surveillance, community prevention programs, maternal health-focused interventions, and development of a system to assess impacts on pregnant individuals, infants, and children.",
"modified": [
"Provisions expand or modify the program's scope and strategies as part of the comprehensive overdose and morbidity program administered by the commissioner of health."
]
},
"citation": "144.0528",
"subdivision": "Subdivision 2"
}
]